As temperatures rise, so does the risk of heat-related illness—especially for people taking certain prescription drugs.

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

A phase 2 trial evaluated the efficacy and safety of lorundrostat in hypertensive patients with chronic kidney disease (CKD) and albuminuria.

Mineralys Therapeutics announced positive topline results from its phase 2 Explore-CKD trial, in which lorundrostat lowered ...

Adding zilebesiran to a thiazide diuretic or calcium channel blocker may lead to further blood pressure reduction in patients with uncontrolled hypertension. Zilebesiran added to hypertension ...

In a major step forward for blood pressure treatment, the US Food and Drug Administration (FDA) has approved WIDAPLIK, a new ...

Merck said that a phase-three study of its pulmonary arterial hypertension treatment met its primary endpoints.

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

Modern-day hypertension causes hidden damage even when ‘controlled’. Doctors are no longer treating blood pressure the same ...

Hypertension is high blood pressure. It is generally defined in adults as systolic blood pressure greater than or equal to 140mmHg and/or diastolic blood pressure greater than or equal to 90mmHg.